Skip to main content

Terry McDonnell

VP, Patient Care & Sys Chief Nurse Exec
School of Nursing

Overview


  • Vice Dean for Clinical Affairs, Duke University School of Nursing
  • Senior Vice President & Chief Nurse Executive, Duke University Health System


THERESA MCDONNELL
Dr. is a transformational healthcare leader with 25 years of experience driving strategic innovation, operational efficiency, and patient-centered excellence across multi-billion-dollar health systems. As Chief Nursing Executive at Duke University Health System, she oversees a workforce of 10,000+ nurses and leads operations across three hospitals, 150+ ambulatory clinics, and a rapidly expanding network that includes a new acute care hospital and an additional hospital acquisition. She also serves as Vice Dean for Clinical Affairs & Innovation at Duke University School of Nursing, bridging healthcare delivery with academic excellence to shape the future of nursing leadership.

Throughout her career, Dr. McDonnell has redefined nursing excellence, championing workforce transformation, cost-efficiency, and innovative care models. She spearheaded Duke’s new framework for nursing excellence, a globally informed, data-driven alternative to outdated accreditation models like Magnet, ensuring scalable, real-world impact. She also leads the Duke Nursing Innovation Hackathon, a pioneering initiative that empowers frontline nurses to identify challenges, develop solutions, and secure funding to drive meaningful improvements in patient care.

Previously, as Senior Vice President of Operations & Chief Nursing Officer at Seattle Cancer Care Alliance (now Fred Hutchinson Cancer Center), she led a $1.7B specialty hospital system, overseeing 1,500 employees and managing large-scale transformation, including a major merger and acquisition with Fred Hutchinson Cancer Research Center. She played a key role in securing $525M in financing for major infrastructure projects and led efforts that delivered a 30% revenue increase over four years. Her strategic leadership also turned a pharmacy operations deficit into $2.8M in revenue through contract renegotiations and operational efficiencies.

At Massachusetts General Hospital (MGH), Dr. McDonnell held progressively senior leadership roles, overseeing 22 disease centers and leading multi-disciplinary teams managing over 450 patients daily. She pioneered a financial care coordination model, recovering $1.4M in potential insurance denials within four months, and helped scale innovative care delivery models, including a nurse-led patient navigation system that became an industry benchmark. A practicing oncology nurse practitioner, Dr. McDonnell ensures that executive leadership remains connected to frontline care. She is deeply engaged in shaping national healthcare policy, advocating for licensure expansion and workforce models that elevate NPs and RNs into executive decision-making roles to address system-wide workforce shortages.

Dr. McDonnell is a respected global thought leader, regularly delivering keynote addresses and panel discussions at major healthcare summits worldwide. She has spoken at Harvard Medical School, ASCO, The Atlantic Live, the Singapore Nursing Conference, and multiple international healthcare forums, sharing insights on nursing innovation, workforce transformation, and the intersection of technology and patient care. Her expertise has been featured in leading medical publications, reinforcing her influence in shaping the future of healthcare on a global scale.

She holds a Doctor of Nursing Practice and a Master of Science in Nursing from MGH Institute of Health Professions and serves on multiple boards, including Watts College of Nursing, Durham County Hospital Corporation, and Durham Technical College Board of Advisors, shaping the future of healthcare and nursing education.

Current Appointments & Affiliations


VP, Patient Care & Sys Chief Nurse Exec School of Nursing

In the News


Published July 26, 2023
Terry McDonnell Selected as Chief Nurse Executive for Duke University Health System
Published August 24, 2015
Hyperthermic Intraperitoneal Chemotherapy: Moving Toward Improved Outcomes

View All News

Recent Publications


American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.

Journal Article Journal of clinical oncology : official journal of the American Society of Clinical Oncology · January 2021 This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for moving for ... Full text Cite

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.

Journal Article Journal of the National Comprehensive Cancer Network : JNCCN · March 2020 The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was reported on January 20, 2020, in Snohomish County, Washington. At the epicenter of COVID-19 in the United States, the Seattle Cancer Care Alliance, Fred Hutchinson Can ... Full text Cite

Pilot Study of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer.

Journal Article Journal of pain and symptom management · December 2015 ContextDyspnea is a common symptom in patients with advanced cancer that interferes with functional ability and quality of life (QOL). Although few evidence-based treatments for dyspnea exist, prior studies show support for nonpharmacological inte ... Full text Cite
View All Publications

External Links


LinkedIn Profile